197 followers
RT @FrontOncology: New research: Angustoline Inhibited Esophageal Tumors Through Regulating LKB1/AMPK/ELAVL1/LPACT2 Pathway and Phospholipi…
RT @FrontOncology: New research: Angustoline Inhibited Esophageal Tumors Through Regulating LKB1/AMPK/ELAVL1/LPACT2 Pathway and Phospholipi…
New research: Angustoline Inhibited Esophageal Tumors Through Regulating LKB1/AMPK/ELAVL1/LPACT2 Pathway and Phospholipid Remodeling: Esophageal cancer is a type of gastrointestinal carcinoma and is among the 10 most common causes of cancer… https://t.co/y